Greco Theresa 4
4 · OptimizeRx Corp · Filed Aug 25, 2025
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Greco Theresa
Chief Commercial Officer
Transactions
- Award
Common Stock
2025-08-21+15,625→ 75,981 total - Award
Stock Option
2025-08-21+35,156→ 35,156 totalExercise: $16.14From: 2026-08-21Exp: 2030-08-21→ Common Stock (35,156 underlying)
Footnotes (2)
- [F1]Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.
- [F2]The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.